FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4549511000001102: Molipaxin CR 150mg tablets (Aventis Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17888301000001117 Molipaxin CR 150mg tablets (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17888401000001113 Molipaxin CR 150mg tablets (Aventis Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Molipaxin CR 150mg tablets (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Is a Trazodone 150mg modified-release tablets true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has active ingredient Trazodone hydrochloride false Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Is a Molipaxin CR true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has specific active ingredient Trazodone hydrochloride true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has active ingredient Trazodone true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Molipaxin CR 150mg tablets (Aventis Pharma) 28 tablet Is pack of False Molipaxin CR 150mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Molipaxin CR 150mg tablets (Aventis Pharma) 28 tablet Has AMP True Molipaxin CR 150mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start